Bulltick Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Buy
660
+296
+81% +$302K 0.16% 64
2026
Q1
$335K Sell
364
-8
-2% -$8.11K 0.07% 104
2025
Q4
$400K Sell
372
-1,690
-82% -$1.62M 0.08% 89
2025
Q3
$1.57M Sell
2,062
-898
-30% -$668K 0.37% 59
2025
Q2
$2.31M Buy
2,960
+50
+2% +$38.9K 0.57% 47
2025
Q1
$2.4M Buy
2,910
+1,851
+175% +$1.54M 0.64% 45
2024
Q4
$818K Sell
1,059
-1,637
-61% -$1.36M 0.19% 77
2024
Q3
$2.39M Buy
2,696
+2,449
+991% +$2.2M 0.58% 46
2024
Q2
$224K Buy
+247
New +$198K 0.06% 90

Other funds holding LLY

Bulltick Wealth Management's LLY Position: Q2 2026 in Review

Bulltick Wealth Management increased its Eli Lilly (LLY) stake by 81% in Q2 2026, buying an estimated $302K and bringing the position to 660 shares worth $792K. The position accounts for 0.16% of the portfolio, ranked #64.

Bulltick Wealth Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.4M in Q1 2025. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bulltick Wealth Management held 660 shares of Eli Lilly worth $792K as of Q2 2026.
  • Bulltick Wealth Management bought 296 Eli Lilly shares in Q2 2026, an estimated $302K.
  • Eli Lilly made up 0.16% of Bulltick Wealth Management's portfolio in Q2 2026, its #64 holding.
  • Bulltick Wealth Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Bulltick Wealth Management's Eli Lilly position peaked at $2.4M in Q1 2025.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bulltick Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.